OBJECTIVE: We aimed to investigate if endothelin 1 concentration at day 3 postnatal age could be used as a predictive marker for development of bronchopulmonary dysplasia in preterm neonates with respiratory distress syndrome.
METHODS: This prospective observational study was done on 69 preterm neonates with gestational ages between 28 and 34 weeks and diagnosed as having respiratory distress syndrome. Serum concentrations of endothelin 1 was measured for all patients at day 3 of life and they were divided into BPD and No-BPD groups according to whether they developed bronchopulmonary dysplasia or not.
RESULTS: A total of 17 infants were in the BPD group and 52 infants were in the No-BPD group. Serum endothelin 1 was significantly higher in the BPD group (435.39±172.88) compared with the No-BPD group (302.65±49.32) (p < 0.001). Serum endothelin 1 correlated significantly with days spent on mechanical ventilation (r = 0.379, p = 0.022) and days spent on CPAP (r = 0.391, p = 0.001). A serum endothelin 1 cut off value of 302.7 ng/L could predict preterm that will develop bronchopulmonary dysplasia with a sensitivity of 88.24%, and specificity of 61.54%.
CONCLUSION: Serum endothelin 1 is significantly increased at day 3 of life in preterm neonates with respiratory distress syndrome who later develop bronchopulmonary dysplasia (BPD). It seems to be a promising predictive marker for BPD but further studies are needed to find the appropriate time for its measurement.
JobeAH, BancalariE. Bronchopulmonary dysplasia. Am J Respir Crit Care Med2001;163(7):1723–9.
2.
JobeAH. The new bronchopulmonary dysplasia: An arrest of lung development. Pediatr Res1999;46(6):641–3.
3.
BarringtonKJ, FinerNN. Treatment of bronchopulmonary dysplasia. A review. Clin Perinatol1998;25(1):177–202.
4.
JaarsmaAS, BraaksmaMA, GevenWB, Van OeverenW, OetomoSB. Early activation of inflammation and clotting in the preterm lamb with neonatal RDS: Comparison of conventional ventilation and high frequency oscillatory ventilation. Pediatr Res2001;50(5):650–7.
5.
MerrittTA, PucciaJM, StuardID. Cytologic evaluation of pulmonary effluent in neonates with respiratory distress syndrome and bronchopulmonary dysplasia. Acta Cytol1981;25(6):631–9.
6.
MunshiUK, NiuJO, SiddiqMM, PartonLA. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol1997;24(5):331–6.
7.
NiuJO, MunshiUK, SiddiqMM, PartonLA. Early increase in endothelin-1 in tracheal aspirates of preterm infants: Correlation with bronchopulmonary dysplasia. J Pediatr1998;132(6):965–70.
8.
SpiropoulosK, TrakadaG, NikolaouE, et al. Endothelin-1 levels in the pathophysiology of chronic obstructive pulmonary disease and bronchial asthma. Resp Med2003;97(8):983–9.
9.
YanagisawaM, KuriharaH, KimuraS, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature1988;332(6163):411–5.
10.
WanecekM, WeitzbergE, RudehillA, OldnerA. The endothelin system in septic and endotoxin shock. Eur J Pharmacol2000;407(1-2):1–15.
11.
BallardJ, KhourgJ, WerdgK, WangL, Filers-WalsmanBL, LippR. New Ballard score, expanded to include extremely premature infants. J Pediatr1991;119:417–23.
12.
BhaktaKY. Respiratory distress syndrome. In: Manual of neonatal care; 6th edition; edited by ClohertyJB, EichenwaldEC, StarkAR. Lippincott Williams & Wilkins. 2008:323–30.
13.
BenzingJ, StabileO, SzinnaiG, et al. Plasma pro-endothelin-1 and respiratory distress in newborn infants. J Pediatr 16020123517–9.
14.
ProcianoyRS, BenjaminACW, SilveiraRC. Endothelin-1 Levels in Preterm Newborns with Respiratory Distress Syndrome. Pediatr Res2004;56:500.
15.
de VroomenM, Lopes CardozoRH, SteendijkP, FrölichM, BaanJ, van BelF. Endothelin-1 plasma concentration increases in the early phase of pulmonary hypertension development during respiratory distress syndrome: A study in newborn lambs. Early Hum Dev2001;63(1):9–21.
16.
TakahashiM. The role of endothelin-1 in vascular remodeling in vivo. Cardiovasc Res2006;71(1):4–5.
17.
DobynsEL, EellsPL, GriebelJL, AbmanSH. Elevated plasma endothelin-1 and cytokine levels in children with severe acute respiratory distress syndrome. J Pediatr1999;135(2 Pt 1):246–9.
18.
ThompsonA, BhandariV. Pulmonary biomarkers of bronchopulmonary dysplasia. Biomark Insights2008;3:361–73.
19.
TinW, WiswellTE. Adjunctive therapies in chronic lung disease: Examining the evidence. Semin Fetal Neonatal Med2008;13(1):44–52.
20.
EricksonSJ, GrauaugA, GurrinL, SwaminathanM. Hypocarbia in the ventilated preterm infant and its effect on intraventricular haemorrhage and bronchopulmonary dysplasia. J Paediatr Child Health2002;38(6):560–2.
21.
BaumannP, FouzasS, PramanaI, et al. Plasma Proendothelin-1 as an Early Marker of Bronchopulmonary Dysplasia. Neonatology2015;108(4):293–6.
